CPC C12N 5/0602 (2013.01) [A61K 35/39 (2013.01); A61K 35/407 (2013.01); C12N 5/067 (2013.01); C12N 5/0671 (2013.01); C12N 5/0676 (2013.01); C12N 5/0677 (2013.01); C12N 2501/01 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/119 (2013.01); C12N 2501/12 (2013.01); C12N 2501/15 (2013.01); C12N 2501/155 (2013.01); C12N 2501/19 (2013.01); C12N 2501/30 (2013.01); C12N 2501/345 (2013.01); C12N 2501/415 (2013.01); C12N 2501/42 (2013.01); C12N 2501/999 (2013.01); C12N 2503/02 (2013.01); Y02A 50/30 (2018.01)] | 15 Claims |
1. A differentiation medium comprising a basal medium for animal or human cells to which is added one or more receptor tyrosine kinase ligands, a Notch inhibitor, a compound that induces the phosphorylation of SMAD1 or SMAD5, and a TGF-beta inhibitor.
|